OraSure Technologies Says FDA Clears At-Home Urine Collection Kit for STI Testing
MT Newswires Live
Jun 11
OraSure Technologies (OSUR) has received US Food and Drug Administration clearance for its Colli-Pee Dx Urine Collection Kit for use with Roche molecular tests for chlamydia, gonorrhea, trichomoniasis and mycoplasma genitalium, the company said Thursday.
The clearance allows patients to self-collect urine samples at home or in other private settings for testing on Roche's molecular diagnostic systems, OraSure said.
The company said the kit uses its NucleoPrecision technology to stabilize DNA and RNA and maintain sample integrity at ambient temperatures.
Shares of the company were over 3% higher in Thursday premarket trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.